Pharma News

GSK's Mosquirix™ receives positive opinion from European regulators for the prevention of malaria

  • Posted on: 24 July 2015
  • By: PharmaTutor News

GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM, also known as RTS,S, in children aged 6 weeks to 17 months. Following this decision, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunisation programmes once approved by national regulatory authorities.

Trivitron Healthcare launch new tests in newborn screening kit

  • Posted on: 24 July 2015
  • By: Shalini.Sharma

Trivitron Healthcare has added two new products in the newborn screening kit for India. The two new tests are Neonatal IRT and Neonatal Toxoplasma gondii IgM that detect disorders which may harm the newborn in later stages of life. Neonatal IRT can detect disorders affecting the lungs, pancreas, intestine and liver. Whereas, Neonatal Toxoplasma gondii IgM can detect neurological and visual disabilities.

Researchers develop brain implant to Deliver Drugs to the Brain via Remote Control

  • Posted on: 24 July 2015
  • By: Shalini.Sharma

Researchers develop a tiny wireless device that, once implanted in the brain, can be activated by remote control to deliver targeted drugs. Size of device is of the width of a human hair. It may be used to treat pain, depression, epilepsy and other neurological disorders in people by targeting therapies to specific brain areas. The researchers believe that similar, more flexible devices could have applications in other areas of the body too, including peripheral organs. The study is published in the Cell.

Novartis antimalarial medicine receives WHO prequalification

  • Posted on: 24 July 2015
  • By: Shalini.Sharma

Novartis, the world's second largest pharmaceutical company, has announced that its antimalarial medicine Coartem 80/480mg received World Health Organisation (WHO) prequalification, making it the first and only high strength (80/480mg) artemisinin-based combination therapy (ACT) antimalarial treatment available for public sector procurement. This new dosage strength has the potential to improve malaria management.

Randstad India Launches Talent Trends Report – HR Game Changers at the NASSCOM HR Summit 2015, Chennai

  • Posted on: 23 July 2015
  • By: PharmaTutor News

(NewsVoir); Randstad, one of the country’s leading HR service providers, today launched an exclusive ‘Talent Trends Report – HR Game Changers’ at the 12th edition of the NASSCOM HR Summit, held in Chennai. The report offers an overview of the top 15 workplace trends that will shape talent management in 2015 and beyond.

Robotics Helped Apollo Children's Hospital Transform the Lives of 65 Children from India and Abroad

  • Posted on: 23 July 2015
  • By: PharmaTutor News

(Business Wire India); Apollo Children’s Hospital has once again showcased its expertise and technical know-how on implementing some of the latest technologies for the benefit of patients. Surgeries performed at the Children’s Hospital using the da Vinci robot provides patients with all the advantages like quicker discharge time, minimal scarring, smaller incisions and less blood loss that conventional laparoscopy offers over open surgeries.

Researchers found yeast used in the Production of Beer, Bread, Wine can make Better Chocolates

  • Posted on: 23 July 2015
  • By: Shalini.Sharma

New study has found that the same species of yeast used in the production of beer, bread, and wine works particularly well in chocolate fermentation. The research by a team of Belgian researchers was published in Applied and Environmental Microbiology.

Pages